Bob Burrows | Vice President-Investor Relations |
Bob Kramer | President and Chief Executive Officer |
Rich Lindahl | Chief Financial Officer |
Abbey Jenkins | Senior Vice President, Vaccines and Anti-infectives Business Unit Head |
Doug Whit | Senior Vice President, Devices Business Unit Head |
Brandon Folkes | Cantor Fitzgerald |
Jessica Fye | JP Morgan |
Keay Nakae | Chardan |
Boris Peaker | Cowen |
Chris Sakai | Singular Research |
Francois Brisebois | Laidlaw |
Good day, ladies and gentlemen, and welcome to the Emergent BioSolutions Inc.
First Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] I would now like to turn the call over to the company.